PEW

Implantable Transprostatic Tissue Retractor System

Product code
PEW
Device name
Implantable Transprostatic Tissue Retractor System
Device class
Class 2
21 CFR
21 CFR 876.5530
Medical specialty
Gastroenterology, Urology
Marketing pathway
510(K)
Flag
Implant
510(k) clearances (last 3 years)
1
Summaries archived here
0 (direct download)
510(k) clearances (all years, FDA)
11 (all years; only the last 3 years are listed here)

FDA classification definition

The treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men age 50 and above.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (1)

Last three years. Most recent: 2023-09-22.

NumberDecision dateApplicantDevice nameSummary
K2325582023-09-22Neotract, Inc.UroLift 2 ATC Advanced Tissue Control SystemFDA
Official FDA classification page: PEW
Classification and pathway per current FDA publications. Data from openFDA (CC0).